DC Circ. Sides With DEA On Marijuana Classification
Law360, Los Angeles (January 22, 2013, 7:53 PM EST) -- A federal appeals court Tuesday upheld the Drug Enforcement Administration’s decision to maintain marijuana as a Schedule I drug, saying medical marijuana advocacy groups failed to provide Food and Drug Administration-approved clinical trials that show acceptable medical uses for the drug.
Medical marijuana advocates, including Americans for Safe Access, the Coalition to Reschedule Cannabis, Patients out of Time and several individuals, had challenged the DEA’s July 2011 denial of a petition that would reschedule marijuana as a schedule III, IV, or V drug because its Schedule I status restricts the production, sale and use of marijuana by federal law.
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!